David Scott*
Metabolic Syndrome (MetS) is a complex disorder that involves a cluster of metabolic abnormalities, including central obesity, insulin resistance, dyslipidemia, and hypertension. It is a significant public health problem and a leading cause of cardiovascular disease and type 2 diabetes mellitus. The molecular mechanisms underlying the development of MetS are multifactorial and involve a combination of genetic, environmental, and lifestyle factors. In this review, we discuss the molecular mechanisms of MetS and potential therapeutic targets.
Teile diesen Artikel